David E. Griffith

21.0k citations

173 papers · 12.2k indexed · 3 hit papers · h-index 53

Impact in

Small Animals top 0.01%
- Infectious Diseases and Mycology
Microbiology top 0.1%

Papers in

Small Animals 46
- Infectious Diseases and Mycology 45
Infectious Diseases 94
- Tuberculosis Research and Epidemiology 90

Co-authors: Richard J. Wallace Barbara A. Brown‐Elliott Charles L. Daley Timothy R. Aksamit Barbara A. Brown Kevin Winthrop Kenneth N. Olivier Stephen J. Ruoss
Journals: CHEST Journal (19 papers)American Journal of Respiratory and Critical Care Medicine (14 papers)Clinical Infectious Diseases (12 papers)Clinics in Chest Medicine (6 papers)The Journal of Immunology (5 papers)
Partner nations: United States Netherlands Canada

In The Last Decade

David E. Griffith

167 papers receiving 11.8k citations

Hit Papers

align trajectories log scale

Adult Patients With Bronchiectasis 2016 · 251 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2016 CHEST Journal
2007 American Journal of Respiratory and Critical Care Medicine
1993 American Review of Respiratory Disease

Peers

Countries citing papers authored by David E. Griffith

Since Specialization

Citations

This map shows the geographic impact of David E. Griffith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David E. Griffith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David E. Griffith more than expected).

Fields of papers citing papers by David E. Griffith

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David E. Griffith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David E. Griffith. The network helps show where David E. Griffith may publish in the future.

Co-authorship network

The 25 scholars most cited alongside David E. Griffith, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with David E. Griffith Line = papers co-authored together David E. Griffith links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Characterizing changes to harm reduction site operations in British Columbia following the implementation of the decriminalization of drugs: Findings from a provincial survey Harm Reduction Journal ·Farihah Ali, Cayley Russell, L Spasojević, Sameer Imtiaz, V. V. Arkhangel'skaya, Rita Shahin, M. Si TjiptoSubadi, David E. Griffith, G. Kubelka, Rosalind Payne, Jürgen Rehm	2025	1
2	Real-World Patients’ Diagnosis-to-Treatment Journey with Nontuberculous Mycobacterial Pulmonary Disease: A Cross-Sectional Survey Infectious Diseases and Therapy ·Kozo Morimoto, Jack R. Gallagher, Dirk Wagner, David E. Griffith, Jakko van Ingen	2024	3
3	Analysis of alpha‐1‐antitrypsin (AAT)‐regulated, glucocorticoid receptor‐dependent genes in macrophages reveals a novel host defense function of AAT Physiological Reports ·Xiyuan Bai, Jun‐Feng Gao, A. Sorlin, Fidela Clarissa, D. Hanks, David E. Griffith, Bifeng Gao, Robert A. Sandhaus, Hua Huang, Edward D. Chan	2024	1
4	Nontuberculous Mycobacterial Pulmonary Disease: Patients, Principles, and Prospects Clinical Infectious Diseases ·Minh-Vu H Nguyen, Michelle Haas, Shannon Kasperbauer, Vinicius Calado Nogueira de Moura, Fang Yan, John D. Mitchell, Reeti Khare, David E. Griffith, Edward D. Chan, Charles L. Daley	2024	11
5	Understanding the development of tuberculous granulomas: insights into host protection and pathogenesis, a review in humans and animals Frontiers in Immunology ·Jiwon Lyu, Fidela Clarissa, Susan L. Baldwin, Sasha E. Larsen, Xiyuan Bai, David E. Griffith, Véronique Dartois, Threnesan Naidoo, Adrie J. C. Steyn, Rhea N. Coler, Edward D. Chan	2024	6
6	Epidemiology of nontuberculous mycobacterial pulmonary disease in Europe and Japan by Delphi estimation Respiratory Medicine ·Jodie A. Schildkraut, Jack R. Gallagher, Kozo Morimoto, Christoph Lange, Charles Haworth, R. Andres Floto, Wouter Hoefsloot, David E. Griffith, Dirk Wagner, Jakko van Ingen	2020	28
7	Amikacin Liposome Inhalation Suspension for Mycobacterium avium Complex Lung Disease: A 12-Month Open-Label Extension Clinical Trial Annals of the American Thoracic Society ·Kevin Winthrop, Patrick A. Flume, Rachel Thomson, Kevin C. Mange, K O Meyer, E. C. M. Silva, Kozo Morimoto, Stephen J. Ruoss, Luigi Ruffo Codecasa, Jae‐Joon Yim, Theodore K. Marras, Jakko van Ingen, Richard J. Wallace, Barbara A. Brown‐Elliott, Chris Coulter, David E. Griffith	2020	46
8	Randomized Phase 3 Trial of Amikacin Liposome Inhalation Suspension (ALIS) for Treatment-Refractory Nontuberculous Mycobacterial (NTM) Lung Disease Caused by Mycobacterium Avium Complex (MAC) in Adult Patients American Journal of Respiratory and Critical Care Medicine ·David E. Griffith, Gina Eagle, Rachel Thomson, Timothy R. Aksamit, Noriko Hasegawa, Haider Baker Ameen, Doreen Addrizzo‐Harris, Anne E. O’Donnell, Theodore K. Marras, Patrick A. Flume, Michael R. Loebinger, Lucy Morgan, Paola Castellotti, A. T. Hill, Stephen J. Ruoss, Jae‐Joon Yim, Felix C. Ringshausen, Stephen K. Field, James Nezamis, Kevin Winthrop	2018	1
9	Six-Minute Walk Test (6MWT) Performance in Adult Patients Receiving Amikacin Liposome Inhalation Suspension (ALIS) for Treatment-Refractory Nontuberculous Mycobacterial (NTM) Lung Disease Caused by Mycobacterium Avium Complex (MAC) American Journal of Respiratory and Critical Care Medicine ·Kevin Winthrop, Gina Eagle, Rachel Thomson, Timothy R. Aksamit, Noriko Hasegawa, Haider Baker Ameen, Doreen Addrizzo‐Harris, Anne E. O’Donnell, Theodore K. Marras, Patrick A. Flume, Michael R. Loebinger, Lucy Morgan, Luigi Ruffo Codecasa, A. T. Hill, Stephen J. Ruoss, Jae‐Joon Yim, Felix C. Ringshausen, Stephen K. Field, James Nezamis, David E. Griffith	2018	0
10	Therapy of Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis Microbiology Spectrum ·Barbara Seaworth, David E. Griffith	2017	35
11	Emergence of mmpT5 Variants during Bedaquiline Treatment of Mycobacterium intracellulare Lung Disease Journal of Clinical Microbiology ·David C. Alexander, Ravikiran Vasireddy, Sruthi Vasireddy, Julie V. Philley, Barbara A. Brown‐Elliott, Benjamin J. Perry, David E. Griffith, Jeana L. Benwill, Andrew D. S. Cameron, Richard J. Wallace	2016	65
12	Randomized Trial of Liposomal Amikacin for Inhalation in Nontuberculous Mycobacterial Lung Disease American Journal of Respiratory and Critical Care Medicine ·Kenneth N. Olivier, David E. Griffith, Gina Eagle, John P. McGinnis, Ruty Eulália de Medeiros Eufrásio, Dennis Bosman, Charles L. Daley, Kevin Winthrop, Stephen J. Ruoss, Doreen Addrizzo‐Harris, Patrick A. Flume, Daniel Dorgan, Matthias Salathé, Barbara A. Brown‐Elliott, Renu Gupta, Richard J. Wallace	2016	169
13	Binding of CXCL8/IL‐8 to Mycobacterium tuberculosis Modulates the Innate Immune Response Mediators of Inflammation ·Agnieszka Krupa, Marek Fol, Bożena Dziadek, Ewa Kępka, Robinson Herrera Feijoo, Anna Brzostek, Agnieszka Torzewska, Jarosław Dziadek, Robert P. Baughman, David E. Griffith, Anna Kurdowska	2015	63
14	Vimentin Expressed on Mycobacterium tuberculosis -Infected Human Monocytes Is Involved in Binding to the NKp46 Receptor The Journal of Immunology ·Ankita Garg, Peter F. Barnes, Angel Porgador, Sugata Roy, Shiping Wu, Jagpreet S. Nanda, David E. Griffith, William M. Girard, Nenoo Rawal, Sreerama Shetty, Ramakrishna Vankayalapati	2006	144
15	Ethambutol Ocular Toxicity in Treatment Regimens for Mycobacterium avium Complex Lung Disease American Journal of Respiratory and Critical Care Medicine ·David E. Griffith, Barbara A. Brown‐Elliott, Sara Shepherd, Jerry McLarty, Lee D. Griffith, Richard J. Wallace	2005	77
16	Polyclonal Mycobacterium avium Complex Infections in Patients with Nodular Bronchiectasis American Journal of Respiratory and Critical Care Medicine ·Richard J. Wallace, Yansheng Zhang, Barbara A. Brown, David J. Dawson, D. T. Murphy, Rebecca W. Wilson, David E. Griffith	1998	131
17	Clarithromycin Regimens for Pulmonary Mycobacterium Avium Complex. The First 50 Patients American Journal of Respiratory and Critical Care Medicine ·Jacques-Albin-Simon Collin de Plancy, Barbara A. Brown, David E. Griffith, W. M. Girard, D T Murphy	1996	203
18	Tuberculosis Outbreak Among Healthcare Workers in a Community Hospital American Journal of Respiratory and Critical Care Medicine ·David E. Griffith, Ezer H. Benaim, K. K. Khadija, Jacques-Albin-Simon Collin de Plancy, Gerald H. Mazurek	1995	53
19	Initial Clarithromycin Monotherapy for Mycobacterium Avium-Intracellulare Complex Lung Disease American Journal of Respiratory and Critical Care Medicine ·Richard J. Wallace, Barbara A. Brown, David E. Griffith, W. M. Girard, D T Murphy, G O Onyi, V A Steingrube, Gerald H. Mazurek	1994	143
20	Pneumonia in Chronic Obstructive Lung Disease Infectious Disease Clinics of North America ·David E. Griffith, Gerald H. Mazurek	1991	14

About David E. Griffith

David E. Griffith is a scholar working on Small Animals, Infectious Diseases, Microbiology, Epidemiology and Organic Chemistry, having authored 173 papers that have together received 12.2k indexed citations. Recurring topics across this work include Mycobacterium research and diagnosis (116 papers), Tuberculosis Research and Epidemiology (90 papers), Infectious Diseases and Mycology (45 papers), Quinazolinone synthesis and applications (16 papers), Microwave-Assisted Synthesis and Applications (11 papers), Pneumocystis jirovecii pneumonia detection and treatment (10 papers), Infectious Diseases and Tuberculosis (9 papers) and Occupational and environmental lung diseases (8 papers). The work is most often cited by research in Small Animals (4.7k citations), Microbiology (409 citations), Infectious Diseases (7.2k citations), Epidemiology (10.0k citations) and Molecular Medicine (397 citations). David E. Griffith has collaborated with scholars based in United States, Netherlands and Canada. Frequent co-authors include Richard J. Wallace, Barbara A. Brown‐Elliott, Charles L. Daley, Timothy R. Aksamit, Barbara A. Brown, Kevin Winthrop, Kenneth N. Olivier, Stephen J. Ruoss, Antonino Catanzaro and C. Fordham von Reyn. Their work appears in journals such as CHEST Journal, American Journal of Respiratory and Critical Care Medicine, Clinical Infectious Diseases, Clinics in Chest Medicine and The Journal of Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact